Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity

Diabetologia

Volumn 42, Issue 8, 1999, Pages 936-943

  Larsson, H ^a   Ahren B ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dexamethasone; Glucagon secretion; Insulin secretion; Insulin sensitivity; Islet function

Indexed keywords

ARGININE; DEXAMETHASONE; GLUCAGON; INSULIN;

ADULT; ARTICLE; BODY WEIGHT; DIET RESTRICTION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PANCREAS ISLET CELL; PRIORITY JOURNAL;

EID: 0032786955     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051251     Document Type: Article

References (44)

1. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467
2. Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527
3. Kahn SE, Prigeon RL, McCulloch DSK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672
4. Kahn SE, Prigeon RL, McCulloch DK et al. (1994) The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43: 587-592
5. Larsson H, Ahrén B (1996) Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 45: 502-509
6. Larsson H, Ahrén B (1996) Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39: 1099-1107
7. Ahrén B, Pacini G (1997) Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 273: E701-E707
8. Johnston C, Rahgu P, McCullogh DK et al. (1987) B-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. Diabetes 36: 829-837
9. Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992
10. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfeld RL, Polonsky KS (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96: 520-527
11. Swinburn BA, Gianchandani R, Saad MF, Lillioja S (1995) In vivo β-cell function at the transition to early non-insulin-dependent diabetes mellitus. Metabolism 44: 757-764
12. Cerasi E, Luft R (1967) The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55: 278-304
13. Cerasi E, Efendic S, Luft R (1973) Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 2: 794-797
14. Porte D Jr (1991) β-Cells in diabetes mellitus. Diabetes 40: 166-180
15. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte D Jr (1984) Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol 247: E592-E596
16. Kahn SE, Beard JC, Schwartz MW et al. (1989) Increased B-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38: 562-568
17. Ward W.K., Bolgiano D.C., McKnight B., Halter J.B., Porte D. Jr. (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74: 1318-1328
18. Larsson H, Ahrén B (1998) Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41: 1772-1777
19. World Health Organisation (1985) Diabetes mellitus: Report of a WHO study group. Geneva, WHO, Technical Report Series no 727
20. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
21. Cerasi E (1975) Potentiation of insulin release by glucose in man. Acta Endocrinol 79: 511-534
22. Grill V (1981) Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol 240: E24-E31
23. Halter JB, Graf RJ, Porte D Jr (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycaemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946-954
24. Kuhl C, Hornnes PJ (1986) Endocrine pancreatic function in women with gestational diabetes. Acta Endocrinol [Suppl] 277: 19-23
25. Sorensen PL, Brelje TC (1997) Adaptation of islet of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29: 301-307
26. Kahn SE, Larson VG, Beard JC, Cain KC, Fellingham GW, Schwartz RS (1990) Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 258: E937-E943
27. Simonsson E, Ahrén B (1998) Potentiated β-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice. Eur J Pharmacol 350: 243-250
28. DePirro R, Bertolli A, Fusco A, Testa I, Greco AV, Lauro R (1980) Effect of dexamethasone and cortisone on insulin receptors in normal human male. J Clin Endocrinol Metab 51: 503-507
29. Groop PH, Groop LC, Tötterman KJ, Fyhrquist F (1987) The effect of dexamethasone on the enteroinsular axis. Scand J Clin Lab Invest 47: 491-495
30. Ludvik B, Clodi M, Kautzky-Willer A et al. (1993) Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia 36: 84-87
31. Billaudel B, Sutter B (1979) Direct effect of corticosterone upon insulin secretion studied by three different techniques. Horm Metab Res 11: 555-560
32. Barseghian C, Levine R (1980) Effect of corticosterone on insulin and glucagon secretion by the isolated perfused rat pancreas. Endocrinology 106: 547-552
33. Lambillotte C, Gilon P, Henquin JC (1997) Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99: 414-423
34. Ling ZC, Khan A, Delauny F et al. (1998) Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose 6-phosphatase, glucose cycling and insulin release. Diabetologia 41: 634-639
35. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S (1992) The diabetogenic effects of glucocorticoids are more pronounced in low-than in high-insulin responders. Proc Natl Acad Sci USA 89: 6035-6039
36. Grill V, Alvarsson M, Efendic S (1992) Dexamethasone treatment fails to increase arginine-induced insulin release in healthy subjects with low insulin response. Diabetologia 35: 367-371
37. Henriksen JE, Alford F, Ward GM, Beck-Nielsen H (1997) Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia 40: 1439-1448
38. McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42: 128-138
39. Ahrén B, Simonsson E, Scheurink AJW, Mulder H, Myrsén U, Sundler F (1997) Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46: 97-106
40. Ahrén B, Larsson H, Wilhelmsson C, Näsman B, Olsson T (1997) Regulation of circulating leptin in humans. Endocrinology 7: 1-8
41. Larsson H, Ahrén B (1996) Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 81: 4428-4432
42. Larsson H, Elmståhl S, Ahrén B (1996) Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 45: 1580-1584
43. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M (1997) Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46: 313-316
44. Shimabukuro M, Koyama K, Chen G et al. (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94: 4637-4641